Back to Search
Start Over
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
- Source :
- Current opinion in oncology, 23 (6
- Publication Year :
- 2011
-
Abstract
- There have been recent new developments in the treatment of breast cancer that over-expresses HER2 (ERRB2/HER2 positive) and the mechanistic understanding of trastuzumab response. We review these findings and reflect on how they may influence the next generation of clinical trials in this breast cancer subtype.<br />Journal Article<br />Research Support, Non-U.S. Gov't<br />Review<br />SCOPUS: re.j<br />info:eu-repo/semantics/published
Details
- Database :
- OAIster
- Journal :
- Current opinion in oncology, 23 (6
- Notes :
- 1 full-text file(s): application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.ocn803496178
- Document Type :
- Electronic Resource